Give to the Knox Martin Foundation for Brain Cancer Research
Give now to help fund and find the next breakthrough in brain cancer research!
We are no longer accepting donations on this campaign, but there are other ways for you to support us today!
Thank you for visiting the Knox Martin Foundation's Network for Good page.
Despite being first identified in the scientific literature in the 1920s, there are only four FDA-approved drugs to treat Glioblastoma (GBM). Four in 100 years. For Glioblastoma (GBM), the five-year relative survival rate is only 7.2% and median survival is only 8 months.
These devastating statistics attest to the underfunded and under-researched nature of brain cancer treatments – particularly treatments for high-grade gliomas (HGG).
The Knox Martin Foundation for Brain Cancer Research was created to reverse the underfunded and under-researched nature of brain cancer by funding innovative research on the most aggressive forms of brain cancer - Glioblastoma (GBM).
For more information on the Knox Martin Foundation, visit knoxmartinfoundation.org/